China
· Delayed Price · Currency is CNY Wuhan Hvsen Biotechnology Statistics
Total Valuation
SHE:300871 has a market cap or net worth of CNY 5.38 billion. The enterprise value is 5.12 billion.
| Market Cap | 5.38B |
| Enterprise Value | 5.12B |
Important Dates
The last earnings date was Friday, April 17, 2026.
| Earnings Date | Apr 17, 2026 |
| Ex-Dividend Date | Aug 26, 2025 |
Share Statistics
SHE:300871 has 201.78 million shares outstanding. The number of shares has increased by 19.57% in one year.
| Current Share Class | 201.78M |
| Shares Outstanding | 201.78M |
| Shares Change (YoY) | +19.57% |
| Shares Change (QoQ) | -10.99% |
| Owned by Insiders (%) | 5.19% |
| Owned by Institutions (%) | 3.49% |
| Float | 106.47M |
Valuation Ratios
The trailing PE ratio is 18.81 and the forward PE ratio is 23.58.
| PE Ratio | 18.81 |
| Forward PE | 23.58 |
| PS Ratio | 3.09 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | 51.95 |
| P/OCF Ratio | 23.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.52, with an EV/FCF ratio of 49.48.
| EV / Earnings | 17.89 |
| EV / Sales | 2.94 |
| EV / EBITDA | 11.52 |
| EV / EBIT | 15.87 |
| EV / FCF | 49.48 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.93 |
| Quick Ratio | 1.50 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 3.30 |
| Interest Coverage | 23.71 |
Financial Efficiency
Return on equity (ROE) is 14.90% and return on invested capital (ROIC) is 14.44%.
| Return on Equity (ROE) | 14.90% |
| Return on Assets (ROA) | 6.41% |
| Return on Invested Capital (ROIC) | 14.44% |
| Return on Capital Employed (ROCE) | 13.07% |
| Weighted Average Cost of Capital (WACC) | 8.40% |
| Revenue Per Employee | 1.69M |
| Profits Per Employee | 278,535 |
| Employee Count | 1,028 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 4.45 |
Taxes
In the past 12 months, SHE:300871 has paid 38.36 million in taxes.
| Income Tax | 38.36M |
| Effective Tax Rate | 11.79% |
Stock Price Statistics
The stock price has increased by +26.91% in the last 52 weeks. The beta is 0.81, so SHE:300871's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +26.91% |
| 50-Day Moving Average | 25.85 |
| 200-Day Moving Average | 23.28 |
| Relative Strength Index (RSI) | 51.77 |
| Average Volume (20 Days) | 12,897,381 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300871 had revenue of CNY 1.74 billion and earned 286.33 million in profits. Earnings per share was 1.42.
| Revenue | 1.74B |
| Gross Profit | 583.80M |
| Operating Income | 322.80M |
| Pretax Income | 325.31M |
| Net Income | 286.33M |
| EBITDA | 444.86M |
| EBIT | 322.80M |
| Earnings Per Share (EPS) | 1.42 |
Balance Sheet
The company has 610.25 million in cash and 342.05 million in debt, giving a net cash position of 268.20 million or 1.33 per share.
| Cash & Cash Equivalents | 610.25M |
| Total Debt | 342.05M |
| Net Cash | 268.20M |
| Net Cash Per Share | 1.33 |
| Equity (Book Value) | 2.27B |
| Book Value Per Share | 11.14 |
| Working Capital | 721.05M |
Cash Flow
In the last 12 months, operating cash flow was 233.11 million and capital expenditures -129.59 million, giving a free cash flow of 103.52 million.
| Operating Cash Flow | 233.11M |
| Capital Expenditures | -129.59M |
| Depreciation & Amortization | 122.06M |
| Net Borrowing | -38.68M |
| Free Cash Flow | 103.52M |
| FCF Per Share | 0.51 |
Margins
Gross margin is 33.54%, with operating and profit margins of 18.55% and 16.45%.
| Gross Margin | 33.54% |
| Operating Margin | 18.55% |
| Pretax Margin | 18.69% |
| Profit Margin | 16.45% |
| EBITDA Margin | 25.56% |
| EBIT Margin | 18.55% |
| FCF Margin | 5.95% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 1.47%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 1.47% |
| Dividend Growth (YoY) | -23.55% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 17.08% |
| Buyback Yield | -19.57% |
| Shareholder Yield | -18.15% |
| Earnings Yield | 5.32% |
| FCF Yield | 1.93% |
Stock Splits
The last stock split was on May 10, 2021. It was a forward split with a ratio of 1.5.
| Last Split Date | May 10, 2021 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |